Zobrazeno 1 - 10
of 93
pro vyhledávání: '"H.J.G.M. van Megen"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
European Psychiatry, 40, 38. Elsevier Masson
BackgroundPreliminary studies have shown that the addition of the partial NMDA-agonist d-cycloserine (DCS) might be promising in enhancing the results of exposure therapy in obsessive-compulsive disorder (OCD). We examined the effect of DCS addition
Publikováno v:
European Psychiatry. 41:S73-S73
BackgroundThere is an urgent need for an effective psychological treatment for patients with obsessive compulsive disorder (OCD) with poor insight, since this disorder is associated with severe suffering and a low quality of life. The inference based
Publikováno v:
Acta Neuropsychiatrica. 5:23-28
SummaryWe studied the effects of pentagastrin, an analogue of the cholecystokinin tetrapeptide (CCK4), in 15 patients with panic disorder and 15 healthy controls. Three different intravenous dosages of pentagastrin (0.1, 0.3 and 0.6 μ/kg) and placeb
Publikováno v:
European Neuropsychopharmacology. 4:273-275
Autor:
Puck Duits, A.J.L.M. van Balkom, Danielle C. Cath, H.J.G.M. van Megen, M. Klein Hofmeijer, M.A. Van den Hout, Marleen M. Rijkeboer, A.W. Hoogendoorn
Publikováno v:
European Neuropsychopharmacology. 24:S617
Publikováno v:
Progress in neuro-psychopharmacologybiological psychiatry. 18(8)
1. 1.Interest in the biological aspects of panic disorder has been focussed mainly on the noradrenergic and serotonergic systems in the brain. 2. 2. Recently evidence has been found that Cholecystokinin (CCK) receptors in the Central Nervous System (
Publikováno v:
European Neuropsychopharmacology. 12:344-345
Publikováno v:
European Neuropsychopharmacology. 12:352-353
Publikováno v:
European Neuropsychopharmacology. 12:343-344